Back
Royal Gold 10K Form
Sell
47
RGLD
Royal Gold
Last Price:
139.69
Seasonality Move:
3.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | RGLD/Royal Gold Quarterly |
| 2023-11-02 | 10Q | RGLD/Royal Gold Quarterly |
| 2023-08-03 | 10Q | RGLD/Royal Gold Quarterly |
| 2023-05-04 | 10Q | RGLD/Royal Gold Quarterly |
| 2022-11-03 | 10Q | RGLD/Royal Gold Quarterly |
| 2022-08-04 | 10Q | RGLD/Royal Gold Quarterly |
Receive RGLD News And Ratings
See the #1 stock for the next 7 days that we like better than RGLD
RGLD Financial Statistics
Sales & Book Value
| Annual Sales: | $605.72M |
|---|---|
| Cash Flow: | $133.22M |
| Price / Cash Flow: | 21.42 |
| Annual Sales: | $46.26 |
| Price / Book: | 3.06 |
Profitability
| EPS (TTM): | 4.36000 |
|---|---|
| Net Income (TTM): | $287.4M |
| Gross Margin: | $342.96M |
| Return on Equity: | 9.76% |
| Return on Assets: | 8.64% |
Royal Gold Earnings Forecast
Key Royal Gold Financial Ratios
- The Gross Profit Margin over the past 40 years for RGLD is 56.62%.
- The Selling, General & Administrative Expenses for RGLD have been equal to 6.56% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 12.89% of Operating Income.
- The Net Earning history of RGLD is 39.53% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 19 years.
Royal Gold Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | RGLD |
| CUSIP: | 780287 |
| Website: | royalgold.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.34 |
| Quick Ratio: | 2.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 38.94 |
|---|---|
| Forward P/E Ratio: | 22.04 |
RGLD Technical Analysis vs Fundamental Analysis
Sell
47
Royal Gold (RGLD)
is a Sell
Is Royal Gold a Buy or a Sell?
-
Royal Gold stock is rated a Sell
The current Royal Gold [RGLD] share price is $139.69. The Score for RGLD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.